|
2021
|
Invention
|
Cd1d-ligand-compound-containing liposome preparation having improved pharmacokinetics.
The prese... |
|
|
Invention
|
Cd1d-ligand-compound-containing liposome preparation having improved pharmacokinetics. The presen... |
|
2018
|
Invention
|
Haploidentical transplantation enhancer. The purpose of the present invention is to provide a hap... |
|
2017
|
Invention
|
Compound or salt thereof, natural killer t cell activator, and pharmaceutical composition. Proble... |
|
|
Invention
|
Compound or salt thereof, natural killer t cell activator, and pharmaceutical composition. The pr... |
|
2016
|
Invention
|
Nanoparticle-aqueous dispersion liquid of glycosphingolipid.
The purpose of the present inventio... |
|
|
Invention
|
Nanoparticle-water dispersion liquid of glycosphingolipid. The purpose of the present invention i... |
|
2013
|
Invention
|
Immune-tolerance inducer.
The purpose of the present invention is to create an immune tolerance-... |
|
|
Invention
|
Immune-tolerance inducer. The purpose of the present invention is to create an immune-tolerance i... |
|
|
Invention
|
Preparation for preventing or treating type i diabetes. The purpose of the present invention is t... |
